滚动轴承故障诊断及其维护

滚动轴承作为旋转机械的关键零件,对其故障诊断及维护来减小经济损失、延长使用寿命具有十分重要的意义。以故障检测确定失效模式,针对其失效模式的特点提出解决方案使轴承正常工作。同时做好滚动轴承的维护,提高其使用价值,将为机械制造业带来巨大的经济效益和低风险的保障。     

罗非鱼养殖技术之三北方地区罗非鱼当年养成技术

在自然条件下,罗非鱼在我国北方地区适宜生长时间只有4-5个月,在冬季只能依靠电厂余热水或地热资源越冬,随着热电厂的逐步改造和地热资源的减少,利用电厂余热水帮助罗非鱼越冬将越来越困难,罗非鱼越冬成本有所增加。近几年,随着休闲渔业的发展,罗非鱼品质优良且又     

美国畜禽屠宰检疫制度介绍

国务院调整畜禽屠宰管理职能后,畜禽屠宰行业由农业部负责管理,生猪屠宰检疫管理制度亟待进一步完善。本文介绍了美国畜禽屠宰检疫的法律依据、管理体制、检疫人员、检疫的内容和程序,以及检疫出证等内容,希望可以为我国屠宰检疫制度建设提供参考。     

对2014年春季上海市某猪场猪伪狂犬病暴发调查

2014年初,上海市闵行区某猪场妊娠母猪暴发妊娠障碍性疫病,疫病期间共发生34个流产病例,袭击率为11.8%。经现场流行病学暴发调查和实验室检测验证,判定该场暴发猪伪狂犬病疫情,建议立即实施猪伪狂犬病的紧急免疫、加强猪场内部管理并修改免疫程序,最终疫情得到有效控制。     

2012年莱西市奶牛布鲁氏菌病血清学调查和风险因素分析

[目的]估计莱西市奶牛布鲁氏菌病的流行率和地理分布,分析奶牛养殖场间布鲁氏菌病的传播风险因素。[方法]对莱西市1803个养殖户30119头应检奶牛,全部采样,采用虎红平板凝集和试管凝集垂直试验,同时开展奶牛布鲁氏菌病问卷调查。利用GIS、Epi Infor TM 7和SPASS软件,开展横断面研究和case-control研究,分析莱西市奶牛布鲁氏菌病阳性场户的空间分布、布鲁氏菌病流行率和养殖场间的风险因素分析。[结果]莱西市布鲁氏菌病的场户血清流行率是2.55%,个体血清流行率为0.38%;单因素分析发现存栏量、养殖模式、养殖环境、是否有专用产犊场地、挤奶方式、运奶方式、粪污是否分开处理、是否使用机械处理粪便等8个因素与奶牛布鲁氏菌病发生有一定关系（p<0.2）;多因素logistic回归分析表明,存栏量少（10只以下）（OR=4.58,95%CI：1.87-11.23,p=0.001）和散养户集中村饲养（OR=2.21,95%CI：1.05-4.63,p=0.036）与该病发生相关。     

一例猪附红细胞体病的诊治

附红细胞体病是以溶血性贫血、黄疸、发热为主要特征的人畜共患的血液感染性疾病,其病原体为附红细胞体。本病例通过流行病学调查、临床症状观察、尸体剖检和实验室检验,确诊为猪附红细胞体病。在采取综合性防治措施后疫情得到了有效控制。     

Effects of animal liver and bile extracts on biochemical values of rat ethanol‐induced fatty liver

The purposes of this study were to assess the improvement of fatty liver induced by ethanol with animal liver and bile extracts. This research aimed to increase the economic values of animal liver and bile extracts and used these to reduce damage of ethanol‐induced fatty liver. Extracts came from animal liver and bile, including pig bile powder, pig liver extract, a mixture of pig bile powder and pig liver extract, chicken bile powder, chicken liver extract, and a mixture of chicken bile powder and chicken liver extract, and these were fed to Long‐Evans rats. The results showed that rats fed ethanol for long terms could increase values of aspartate transaminase, cholesterol, γ‐glutamy‐transferase and alkaline phosphatase. Pig bile powder could decrease the values of aspartate transaminase, cholesterol and γ‐glutamy‐transferase. The significances also decreased on aspartate transaminase, γ‐glutamy‐transferase and aspartate transaminase, which were carried out with the pig liver extract treatment. These results suggest pig bile and liver extracts have high potential to improve rats' ethanol‐induced fatty liver with serum biochemical parameters.     

Enhancing mucosal immunity in mice by recombinant adenovirus expressing major epitopes of porcine circovirus-2 capsid protein delivered with cytosine-phosphate-guanosine oligodeoxynucleotides

A recombinant replication-defective adenovirus expressing the major epitopes of porcine circovirus-2 (PCV-2) capsid protein (rAd/Cap/518) was previously constructed and shown to induce mucosal immunity in mice following intranasal delivery. In the present study, immune responses induced by intranasal immunization with a combination of rAd/Cap/518 and cytosine-phosphate-guanosine oligodeoxynucleotides (CpG ODN) were evaluated in mice. The levels of PCV-2-specific IgG in serum and IgA in saliva, lung, and intestinal fluids were significantly higher in the group immunized with rAd/Cap/518 and CpG ODN than animals immunized with rAd/Cap/518 alone. The frequencies of IL-2-secreting CD4⁺ T cells and IFN-γ-producing CD8⁺ T cells were significantly higher in the combined immunization group than mice immunized with rAd/Cap/518 alone. The frequencies of CD3⁺, CD3⁺CD4⁺CD8^-, and CD3⁺CD4^-CD8⁺ T cells in the combined immunization group were similar to that treated with CpG ODN alone, but significantly higher than mice that did not receive CpG ODN. PCV-2 load after challenge in the combined immunization group was significantly lower than that in the phosphate-buffered saline placebo group and approximately 7-fold lower in the group treated with CpG ODN alone. These results indicate that rAd/Cap/518 combined with CpG ODN can enhance systemic and local mucosal immunity in mice, and represent a promising synergetic mucosal vaccine against PCV-2.